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Following the technological advances that have enabled genome-wide analysis in most model organisms over the last
decade, there has been unprecedented growth in genomic and post-genomic science with concomitant generation of an
exponentially increasing volume of data and material resources. As a result, numerous repositories have been created
to store and archive data, organisms and material, which are of substantial value to the whole community. Sustained
access, facilitating re-use of these resources, is essential, not only for validation, but for re-analysis, testing of new hypoth-
eses and developing new technologies/platforms. A common challenge for most data resources and biological repositories
today is finding financial support for maintenance and development to best serve the scientific community. In this study
we examine the problems that currently confront the data and resource infrastructure underlying the biomedical sciences.
We discuss the financial sustainability issues and potential business models that could be adopted by biological resources
and consider long term preservation issues within the context of mouse functional genomics efforts in Europe.
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Introduction
In our attempt to better understand the biology of human
disease we are generating increasingly diverse and special-
ized data sets, many of which are extremely large and com-
plex, with the result that when primary data is put in the
public domain it is scattered through an increasing number
of knowledge domain specific databases and bioresources.
These databases contain genomic (including sequencing,
expression and microarray), proteomic (structure and func-
tion) and metabolomic data as well as information about
function, structure, localization and clinical effects of muta-
tions. Furthermore, with the increased attention recently
given to mouse mutants that serve as models for human
disease and the development of novel therapeutic
strategies there has been a proliferation of material
resources serving to support mouse research. Information
on these material resources is commonly presented through
databases such as the International Mouse Strain Resource
(IMSR) [1,2]. Biological databases have consequently
become an important tool in assisting scientists to under-
stand and explain biological molecules and processes, in
addition to their interactions.
Since biological knowledge is distributed worldwide and
therefore among many differently specialized databases, it
is difficult and frequently impossible to ensure preservation
and consistency of information as well as data quality.
Currently, much of the collected data are stored in a
way that does not always guarantee future retrieval
by other researchers [3]. Assured growth, persistence and
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encourage and support data deposition. Additionally, stan-
dardization of data representation and transfer is required
for enabling the integration of existing and new databases.
At present, biological databases cross-reference other
databases with accession numbers or IDs as one way of
linking their related knowledge together. Much current
European effort is being expended in developing modes
of data integration and database interoperability, either
as a ‘one-stop-shop’ federation or more recently in the
development of ‘smart’ clients which integrate data from
multiple sources or run tailor-made workflows [4].
A major problem for most databases is securing financial
support for the bioinformaticians and curators who create
and maintain them [5,6]. Development and maintenance
of databases is a costly activity and while it is hard to gen-
eralize about average costs as these will vary depending
on the resource’s size and complexity, personnel costs
in different countries, etc., we can give an example for
the European Mouse Mutant Archive (EMMA) database
(http://www.emmanet.org/). The informatics for EMMA
require three full time equivalent posts and 13% of the
overall project funding. Even popular databases commonly
lack secure funding and frequently face loss of their
original support after a few years in development. Hence,
long-term sustainability of databases requires adequate
and reliable sources of funding. In this article, we will
give an overview of the current financial support situation,
potential business models that could be adopted by data-
bases for their long-term financial support, and the
attempts that have been made so far.
CASIMIR (http://www.casimir.org.uk), a Coordination
Action funded by the European Commission, focuses on
the dissemination and integration of databases relevant
to the mouse as a model organism for human disease.
The overall aim of the project is to identify the factors
which inhibit the free flow of data and resources for
mouse functional genomics and to determine what is
needed to overcome these in order to establish a frame-
work of interoperable databases with concomitant added
value to the scientific community. Sustainability is a major
challenge and CASIMIR aims to make recommendations
to the European Commission and the community on the
extent to which databases might become self-sustained in
terms of data deposition, usage, development and financial
support. CASIMIR will also examine what potential business
models could be adopted by biological resources for their
financial sustainability and long-term preservation.
Data and biological resources
Publication of experimental results and sharing of the
related research materials have long been key elements
of the life sciences. Indeed scientific progress depends on
the ability of researchers to access and exploit data and
materials reported in publications so that they can subse-
quently build on these findings. Publications also serve as
a means of receiving intellectual credit and recognition
which subsequently enhance a researcher’s career prospects
and potential for research support. It is however no longer
adequate to share data through traditional modes of pub-
lication, and, particularly with high throughput (‘-omics’)
technologies, sharing of datasets requires submission to
public databases as has long been the case with nucleic
acid and protein sequence data. This presents new chal-
lenges in extending the traditional publication model to
the New Biology.
The traditional quid pro quo arrangement, where
authors receive credit and acknowledgements in exchange
for disclosure of their scientific findings, has been
re-evaluated by a US National Academy of Sciences com-
mittee. The responsibility of authors to share data and
materials referenced in their publications, the role of jour-
nals to impose requirements for data and material sharing,
and whether a common set of requirements for sharing
should exist has been closely examined and the concept
of the ‘uniform principle for sharing integral data and
materials expeditiously’ (UPSIDE) [7,8] has been established.
Biological resource centers (BRCs) are centralized reposi-
tories that specialize in storing and distributing materials,
such as mice or ES cells and their associated data. Both
repository and service functions contribute to the needs
of national and international consortia, as well as individual
laboratories and research institutes in support of academic
research programs. A central role for the BRCs is to facili-
tate the principles set out by UPSIDE and embrace the
open-access policy, quality of material, data integration
and sustainability. It is crucial that the scientific community,
public funding bodies and governments acknowledge these
issues as being of primary importance.
In accordance with the aforementioned responsibilities
of authors, journals and BRCs came the recently published
guidelines by the Organization for Economic Co-operation
and Development (OECD) [9] asserting that in order to
comply with the data-sharing imperative, adequate and
reliable sources of funding are required to facilitate the
sharing infrastructure and, as part of that, the long-term
stability of BRCs [10]. If, for financial reasons, BRCs are
unable to perform their tasks under conditions that meet
the requirements of scientific research and the demands
of industry, scientists will either see valuable information
lost or being transferred into a strictly commercial environ-
ment with at least two consequences: (i) blockade of access
to this information and/or high costs and (ii) loss of data
and potential for technology transfer for the foreseeable
future. In either case the effect on both the scientific and
broader community will be detrimental.
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types (e.g. imaging, microarray, phenotypic, etc.) can
include costly processes, requiring expensive consumables
as well as specialized equipment and personnel for their
generation, it can potentially be difficult to fulfil sharing
obligations and make resources available, unless there
is recognition by peers and investment by funding
agencies and the community. This is particularly the case
for material resources such as cryopreserved mouse lines,
for which rederivation and shipping costs are substantial.
Typically, users want to access data from a single web
portal. This can be achieved by storing all the data in one
location in a data warehouse but in cases where there
are multiple data producers, difficulties with data transfer
issues can make a decentralized solution more attractive
[8]. Existing technological infrastructures allow the forma-
tion of a ‘one-stop-shop’ which brings together data from
multiple resources in a single web-interface, enabling col-
lective data querying across different data sets and linking
to biological material.
However, in order to achieve such a multi-resource
portal, there are several barriers to be overcome in conjunc-
tion with some requirements that need to be met. All con-
tributing BRCs should firstly be validated for their data/
information quality according to accepted standards,
and should be continuously updated, both at the level
of material/data as well as incorporation of novel biologi-
cal resources. To achieve this constantly developing
infrastructure, support from both biologists/curators and
bioinformaticians is essential, which is a hindrance to the
maintenance of a number of these databases. Furthermore,
BRCs should all embrace open-access policies upon publica-
tion of the related material, or the existence of simple
material transfer agreements (MTA) and standards
should be implemented so that portals can integrate and
become easily interoperable. Such restrictions should
be eliminated as much as possible, especially for academic
applications, to promote data sharing [11].
Problems encountered
As previously mentioned, one of the biggest concerns
that BRCs encounter is their financial sustainability
beyond their creation and after the original funding has
ended [6]. Typically, BRCs may obtain an initial funding
for a project relatively easily where a community need is
clear. As a result many biological resource databases
have been designed in various research institutes and are
commonly created without meeting validated quality stan-
dards. Furthermore, they are developed with varying
formats and quality, and occasionally exhibit limited inter-
national access. Consequently integration of these BRCs
into the international data network is often not possible.
Searching for mice or ES cells then becomes time
consuming and difficult and can result in redundancy of
resources. For prolonged data archiving and curation,
long term financial support is required which is frequently
a stumbling block for BRCs today. Lack of secure funding
may frequently result in database or biological resource
decommissioning as well as loss of valuable and irreplace-
able data. A preferable outcome is the preservation of
these unfunded resources by a funded resource with the
capacity to do so. The TBASE (http://www.bioscience.org/
knockout/knochome.htm) database is an example of this;
in this case all the data, which would have otherwise
become outdated or lost, was transferred and is now
hosted at Mouse Genome Informatics (http://www
.informatics.jax.org/) at the Jackson Laboratory. An obvious
question that arises is to examine who would provide
the required financial support for the archiving of these
valuable data and the distribution of biological material,
as well as the customer service/user support. How
does one support a useful BRC to ensure appropriate
data/information archival and curation?
Models examined
Whereas publicly funded BRCs and databases are expected
to embrace an open-access policy and be accessible to the
broad scientific community, with some notable exceptions,
such as the deposition of 300 000 ESTs into GenBank
by Merck in 1995, pharmaceutical and biotechnology com-
panies generally do not share data for free. Some compa-
nies like Incyte (http://www.incyte.com/), a provider of
integrated platforms of genomic technologies, apply a sub-
scription fee, or pay-per-view policy. Other companies, such
as Exelixis (http://www.exelixis.com/), employ marketing
and public relations policies to help them sell their products
or demonstrate their product and technology utility.
Finally, some corporations like Wyeth (http://www.wyeth
.com/), engage in research collaborations for research
they are unable to perform in-house, an effort which indi-
rectly promotes knowledge and dissemination. There are
several examples however of very successful public–private
models which have, or still do, greatly benefit the not-for-
profit sector. For a brief period following their funding
crisis in 1996, Swiss-Prot (now Uniprot) a dual-tier system
was instituted where for–profits paid an annual fee to
the database, whereas academic researchers had free
access, effectively being cross-subsidized. Interestingly,
Swiss-Prot was ‘re-nationalized’ and completely free
access for all users was restored following a large injection
of funding from the US NIH in 2002. An example where
public–private partnership has successfully collaborated
in the long-term is the ‘Structural Genomics Consortium’
(http://www.sgc.ox.ac.uk/) placing protein structures of
relevance to human health into the public domain, free
from restrictions on use.
.............................................................................................................................................................................................................................................................................................
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obtain biological materials and gain access to associated
databases. Varying fee structures can be applied for
access depending on the nature of the biological material,
the status and constraints of the institution holding the
resources and its relationship with the public and private
sectors, national policies and relevant international
frameworks.
There are two major models that have been examined
and are currently in use by different BRCs:
Cost recovery
Cost-recovery is defined as recovering the full or par-
tial cost of a project or service, including both its
fixed and marginal costs. Typically, it is discussed in
the context of cost recovery from users of the services
provided, although direct grant funding can be consid-
ered as a particular form of cost recovery and is discussed
below.
The problems with cost-recovery models for database
or, more acutely, BRC sustainability, are articulated by
David [12]. In a ‘Ramsey’ model of pricing, the groups
that are willing and able to pay more for a fixed level of
service over a long period are assigned a larger share of
core costs than user groups who are more cost sensitive,
and whose inability to pay would be detrimental to the
public good. In such a model, the high fixed-cost subscrip-
tions would typically be paid by for-profit organizations,
whilst the marginal costs of providing the data or
bioresources would be charged to end-users working in
universities and not-for-profit organizations. Fixed-cost
subscriptions might also be paid by public funding agencies
or not-for-profit organizations in respect of their long-
term fixed demand for information to allow access to
their grantees or employees at a nominal cost. This can
be taken to one extreme, as in some of the models for
databases discussed below, where one or more agencies
cover all fixed and marginal costs by a grant for the
common good, and there is no cost passed on to end-
users or other organizations. The other extreme is where
all costs are recovered from end-users. The problems with
the dual layer Ramsey cost-recovery model rest with the
willingness of companies and public institutions to fund
the high and long-term fixed costs, the segmentation of
costs between fixed and distributive components (not
an easy calculation to make given the complex ongoing
activities of open biological databases) and what would
be considered a fair cost for the service to individual
users, whilst still maintaining public good. We are not
aware of any resource that has been able to recover all
costs through a single layer system with fixed and marginal
costs recouped directly from individual end-users. David
also argues against such an approach, especially for data-
bases in which the true marginal cost of each transaction
is actually very low: ‘commitment to implement them
(user charges) on the part of the rich societies would most
likely result in pricing the use of scientific information and
data beyond the reach of many poorer societies’. There is
a political and social dimension here, along with the gen-
eral issue of the potential harm to the rate of scientific
advance caused by the imposition of cost barriers to data
and materials access.
However, a partial ‘cost-recovery’ model, where mar-
ginal and a variable fraction of fixed costs are recouped
from end-users, is a clearly viable funding approach for
the partial support of core services which augments direct
grant funding to the resource; a useful strategy used for
income supplementation in order to sustain the running
of infrastructure. In some current examples, core costs
are met by one funding agency for the benefit of all, for
example the MMRRCs in the USA where core funding
is provided by the National Institutes of Health (NIH) [13],
and some of the marginal cost recovered from end-
users, or as with the Human Genome Variation
database (HGV-G2P; http://www.hgvbaseg2p.org/index)
where there are multiple agencies and organizations
covering both the core and marginal costs and data is
freely available [14].
In the case of the BRCs, a cost-recovery model by which
revenue might be secured to support the infrastructure
is ‘fee-for-service’, but despite the contribution of fees
we are not aware that even true full marginal costs are
met in this way by any BRC, let alone core costs, and
income from ‘fee-for-service’ has a significant but only miti-
gating effect on the overall cost of running the core
resource. This is a consequence of setting the marginal
costs, in the Ramsey sense, at levels which are sustainable
for investigators on fixed grant income, and to a large
degree tacitly negotiated with funding agencies as to
what level of cost is acceptable.
Several BRCs utilize the partial cost-recovery model in
conjunction with other methods of financial support.
One example of this is the EMMA which provides a free
archiving repository for mouse mutant lines. The bulk of
the costs of actually distributing the mice are expected to
be recovered from the fees charged to both for- and not-
for-profit end-users who order the material. However,
the considerable costs associated with archiving the mice,
supporting the informatics and project organization are
still provided from a European Commission FP7 grant as
well as national research programmes and institutional
funds at individual partner sites. Other examples include
the Drosophila Genomics Resource Center (https://
dgrc.cgb.indiana.edu/), the Bloomington Drosophila Stock
Center at Indiana University (http://fly.bio.indiana.edu/)
and the John Innes Centre Genome Laboratory (JGL;
http://jicgenomelab.co.uk/).
.............................................................................................................................................................................................................................................................................................
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A common model for the financial sustainability of a
resource is through allocated funds obtained from a
single public institution towards the respective BRC. This
approach is most commonly applied to data resources. An
example of this model are the databases operated by
the National Center for Biotechnology Information (NCBI;
http://www.ncbi.nlm.nih.gov/) which receives funds from
both the National Library of Medicine (NLM; http://
www.nlm.nih.gov/) and the NIH (http://www.nih.gov/).
The role of industry versus the role
of government
Both industry and government agencies have provided
support to BRCs. Some BRCs use a dual support system,
where public research agencies and not-for-profit organiza-
tions provide grants for specific projects and programs,
which may involve consortia of laboratories, whereas gov-
ernment funding agencies provide block grant funding to
Research Institutes to support the research infrastructure
and enable the institutions to undertake ground-breaking
research of their choosing. Such funding also provides
the capacity to undertake research commissioned by
the private sector, government departments, charities, the
European Union and other international bodies. The
European Bioinformatics Institute (EBI; http://www.ebi
.ac.uk/) is a good example of this dual funding support
practice, as it is funded by the governments of EMBL’s
member states, as well as other major funders such as
the European Commission, Wellcome Trust, US National
Institutes of Health, UK research councils and some industry
partners.
Furthermore, there are specific ‘projects’ (e.g.
biobanks—collections of cells, tissues, blood, DNA samples)
that may have a two-fold character, as collections of
both samples and data. These may be operated under the
auspices of either the public sector institutions (i.e. univer-
sity departments) or of individual or private bodies (e.g.
pharmaceutical companies). Irrespective of the responsible
institution, they may be funded from public or private
resources. One could expect that some funding from
these projects may be dedicated towards resource integra-
tion and dissemination. Good examples of this are mutant
cryorepositories which provide the facility to cryopreserve
and distribute mouse lines as sperm or frozen embryos.
These are typically partly institutionally funded but
receive additional funding from specific projects, such as
the EU-funded EMMA project.
Development of the business model aforementioned,
as a supplementary activity towards cost recovery, is not
as effective for underpinning the infrastructure, as it does
not cover Full Economic Costing (real costs of running an
infrastructure, including all costs above and beyond con-
sumables and direct staff costs; these involve rent for
space, overheads, staff salary/benefits, staff training and
any business development support) or opportunity costs.
With regard to industry investment, association through
advertising could be seen as a potential revenue generator,
useful to provide valuable support towards further devel-
oping the resource assets (e.g. validated assays, new appli-
cations). However, it is doubtful that the benefits would
be enough to cover the infrastructure and the business
development overhead will outweigh any overall benefit.
In order for companies to be drawn towards website adver-
tising, visibility of at least 10000 visitors per month is
required [5]. Considering the specialization of biological
databases, even many of the big ones do not have this
volume of traffic, and therefore attracting commercial
clients makes it almost impossible to raise enough revenue
to support BRCs.
A model with potential: academic–
commercial partnership on core
competencies
Another model that has been examined and appears
to have great potential in being successful towards the
prolonged financial sustainability of BRCs is an ‘academic-
commercial partnership’. Academic laboratories, mostly
sustained by institutional funding, or grants, develop new
applications and tools as well as analysis systems, whereas
concurrently they support the identification of communal
needs and define quality standards all of which prove
to be beneficial to the research community. Commercial
organizations on the other hand, which are financially
supported by their own commercial activities, function
in a collaborative way between research and licensing
(Pharmaceutical and Biotechnology companies) and oper-
ate as service providers, offering standard technologies
and quality systems, sales and marketing distributors.
In the context of CASIMIR, and in the course of examin-
ing the potential financial models that resource centres
could adopt for their maintenance, the MUGEN Mouse
database (MMdb; www.mugen-noe.org/database/), a
virtual mutant mouse repository created in the context
of the MUGEN Network of Excellence (www.mugen-noe
.org/) to provide on-line information on murine models
for immunological disease [15], serves as a use-case exam-
ple. For demonstration purposes, MMdb, taking advantage
of its simplicity and useful size, currently provides direct
trial links, under the gene information, to Invitrogen
(http://www.invitrogen.com/) and Geneservice (http://
www.geneservice.co.uk/) through the gene IDs (Figure 1).
The user may therefore be directly transferred to
the respective product page, where all the gene-related
.............................................................................................................................................................................................................................................................................................
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teins, assay kits, etc.) are presented. Ensuing the overall
discussions regarding financial sustainability of databases,
and following a successful connection, MMdb has
approached Invitrogen as well as other potential compa-
nies, asking them to link their individual products with
the respective mouse model and also examine the possibil-
ity that such big vendor corporations would be interested
in linking with MMdb and explore their willingness
towards marketing/advertisement service charges which
could help maintain the database. Indeed Invitrogen
responded very positively towards this effort, and has
pledged to undertake a survey with regard to the com-
pany’s perspectives and willingness to financially support
this effort. Unfortunately, the overall response was not
as expected, since only one out of the six companies
approached responded to the request, demonstrating
some enthusiasm and feedback in this attempt. The
suggested approach, although in principle appearing to
have great potential, in practice is somewhat harder
to achieve, as companies are not that willing to sponsor
academic institutions. This may of course be a matter of
time and should big vendor corporations be appropri-
ately primed this arrangement may indeed prove to be
beneficial towards prolonged sustainability. Finally,
such an approach would only be applicable provided the
fundamental unit of information is related to company
goods (e.g. reagents) and will therefore only apply to a
fraction of databases.
The role of consortia
The European Commission in support of the fifth and
sixth Framework Programmes has over the last seven
years sponsored a number of projects generating biological
experimental data, including sequences, and material
resources such as biological collections. Some of these
consortia (e.g. EUMORPHIA, EUCOMM, EUMODIC,
EUREXPRESS, EMMA, MUGEN, etc.) also serve as liaisons
towards the European Commission, giving advice with
respect to specific areas of interest and their respective
needs for further development and also suggesting poten-
tial future directions that the European Commission should
pursue.
Furthermore, the European Commission has also sup-
ported some co-ordination actions (e.g. PRIME, CASIMIR)
especially to organize and bring together the individual
European efforts as well as survey the scientific commu-
nity needs. These consortia also play an intermediary
role between the scientific community and the European
Commission, making recommendations to the latter with
respect to the needs that the scientific community has,
thus aiming to improve scientific development. This inter-
active relationship allows networks to lobby both national
Figure 1. Sample screen shot of MMdb ‘IL-10’ gene with the direct trial links, under the gene information, to Invitrogen and
Geneservice through the gene ID.
.............................................................................................................................................................................................................................................................................................
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cation practices and for funders to approach and consult
with the network with regard to issues and priorities.
The CASIMIR consortium, in an effort to evaluate the
financial sustainability models adopted by existing biologi-
cal databases and resources, has examined the responses
obtained from MRB’s (Mouse Resource Browser) online
questionnaire (http://bioit.fleming.gr/imouse/). The overall
response was satisfactory; indeed there were 79 responses
obtained covering resources from around the world. The
majority of responders were of European origin (51%),
followed by American resources (38%), while the remain-
ing 11% of obtained responses were from databases and
resources from Canada, Japan and Australia (Figure 2).
As expected, the majority of biological resources and
databases were created as part of a particular funded
project. Of the 50 resources that responded to this partic-
ular question, 68% confirmed that their database or
resource indeed originated from a funded project, while
the remaining 32% did not (Figure 3). On the other
hand, despite the fact that in the majority of cases the orig-
inal financial support came from funded projects, upon
completion/expiration of these three- or five-year projects,
financial maintenance of the respective resource was
achieved through Institutional or Government funding
(44 and 36%, respectively), while only the remaining 20%
of biological databases were funded by other sources
such as the industry (4%) (Figure 4). Through examination
of the financial maintenance achieved by some resource
centers for sustaining their core activities and assessment
of how these may be applied towards long term preserva-
tion of databases it has become evident that most data-
bases obtain an initial funding for a particular project,
and then need to be further maintained through institu-
tional or government funds.
Recommendations for the mouse
functional genomics community
Having reviewed extensively the substantial amount of
information provided by BRCs and the importance of
making the data freely available to the research commu-
nity, it is clear that it is imperative to promote data preser-
vation and dissemination, for secure storage and easy
retrieval of information. Moreover, it will often be appro-
priate that BRC databases should not exist as classical data
warehouses, but rather a cluster of activities supporting
the community of academic and commercial researchers
all aiming, through a unified effort, towards providing
information for the progression of research. CASIMIR is
indeed already taking action in the direction of promoting
database integration and interoperability, and should
Questionnaire Responses
(Total No. of responses: 79; ~27%) 
41; 51%
2; 3%
30; 38%
3; 4% 3; 4% Canada
EU
Japan
USA
Australia
Figure 2. Graph representing the origin of each biological
database or resource that responded to the online question-
naire. 51 percent of resources are in Europe, 38% in the USA,
4% in Australia and Canada, and 3% in Japan.
Was your resource created as part 
of a particular funded project? 
(Total No. of responses: 50) 
34; 68%
16; 32% Yes
No
Figure 3. Representation of the financial support originally
obtained for the creation of each biological database or
resource. 68 percent of resources were created as part of a
particular funded project, while 32% were not.
How is your resource currently
financially maintained?
(Total No. of responses: 45)  
16; 36%
2; 4%
0; 0%
7; 16%
20; 44%
Institutional Funding
Government Programme
Industry
Advertisement
Other
Figure 4. Representation of the financial support currently
provided to maintain biological databases and resources.
44 percent of resources subsidize through institutional funds,
36% through Government programs, 4% from Industrial
funds and 16% from other sources.
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data as recommended by UPSIDE [7,8] this would obviously
greatly promote research activity.
Furthermore, following the close examination of
setbacks that most of these BRCs today encounter and
existing business models that they could potentially adopt
in order to reinforce database sustainability, the conclusion
that can be drawn is that long-term sustainability of
databases requires adequate and reliable sources of
funding so that data is preserved and disseminated
properly.
With regard to the business models examined in this
manuscript as potential patterns to be adopted by BRCs
for their financial sustainability, the ‘full cost recovery’
model which has already been tested by some resources
has proved to not be viable for data resources. The ‘fee-
for-service’ or ‘partial cost-recovery’ model is already prac-
ticed, at least in part, by some BRCs. For data provided
this is contrary to the UPSIDE recommendations, according
to which data should be shared, but in practice most
BRCs employing this approach are providing material
resources, which have substantially higher costs and it
is open to debate if these can reasonably be provided
completely free of charge. The most promising model
examined in this manuscript is ‘Institutional Funding’
which seems to provide a secure environment for the
BRCs to develop and implement a secure data management
plan and potentially ensure the long-term accessibility
of the related project data. Indeed agencies around the
world such as the NIH and the EU through ELIXIR (http://
www.elixir-europe.org), are now turning their attention
to working out how best to assist the growth of validated
and accessible databases. This should involve, at the least,
development of policies for evaluating proposals on data-
bases and associated analytic tools, for their sustained
funding, and for ensuring that the data deposited remain
accessible long after the project originators have moved
on. The aforementioned model of academic-commercial
partnership may appear to have potential should vendor
corporations become involved in this collaborative effort.
In all cases, funders should be aware of the need to support
viable career paths for the software engineers and bioin-
formaticians who create the knowledge environments and
curate the data in them. In order to obtain value for
money, it will be vital for funding agencies to carefully
select the databases they choose to support and then to
support them for the long term. They must encourage
the sustained availability of these data and build incentives
for the development of cross-querying capability.
Discussion
The last decade has seen a rapid growth in the genome
sciences, through modern advances in biological sciences,
molecular biology and genetics, which have enabled
genome-wide analysis in most model organisms, and
the generation of high-throughput of data. To facilitate
the secure storage and easy retrieval of this substantial
amount of information, numerous data and biological
material resources have been created which are of signifi-
cant value and should be openly accessible to all scientists
for the purposes of result validation, testing new hypoth-
eses and developing new technologies/platforms. An inev-
itable consequence that has arisen from this data and
biological material resource boom is the significant chal-
lenge in the access and sustainability of these databases.
Preservation of these centralized repositories is therefore
imperative. CASIMIR continues to review the potential
business models that biological resources could adopt for
their financial sustainability and prolonged data storage
and aims to appropriately make recommendations to the
funding agencies and the community at large.
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